Is Cyclacel Pharmaceuticals, Inc. (CYCC) a Buy, Sell, or Hold?
NASDAQ : CYCC
Cyclacel Pharmaceuticals, Inc. — Analyst Ratings
$6.365 USD
-$0.41 (-5.98%)
- Volume
- 219.91K
- Average Volume
- 1.81M
- Market Capitalization
- $10.61M
- P/E Ratio
- -2.19
- Dividend Yield
- 0.00%
- Price Target
- $1.00
- Year High
- $597.60
- Year Low
- $3.08
- Day High
- —
- Day Low
- —
- Payout Ratio
- -$0.03
- Current Ratio
- $7.06
Analyst Consensus Summary
Consensus Rating
N/A
7 Analysts
Rating Score
0/5
Recommendation Strength
Upside/Downside
536.5%
vs Current Price
Price Target
$1.00
Average TargetPrice Target Range
Lowest Target
$1.00
536.5% UPSIDE
Average Target
$1.00
Median Estimate
Highest Target
$1.00
536.5% UPSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 7
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 5 | 2 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Roth Capital | Jonathan Aschoff | $1 | $1.14 | 2024-10-23 10:31 AM | -12.3% |